Clinical Trial Update: 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a radiolabeled monoclonal antibody (177Lu-J591) in combination with ketoconazole for prostate cancer; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 177Lu-J591
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-07-19